CML refers to Chronic Myeloid Leukemia, a cancer of the blood and bone marrow. The condition is caused by a genetic mutation that leads to abnormal white blood cell growth. CML is a rare type of leukemia, accounting for approximately 10% of all leukemia cases.

CML produces abnormal white blood cells called myeloid cells, which fight infections in the body. As a result, these cells accumulate in the bone marrow and blood of people with CML, which crowds out normal blood cells. This can lead to symptoms such as fatigue, weakness, fever, and an enlarged spleen.

CML is a chronic blood cancer that progresses slowly, and many people are asymptomatic for many years without showing any signs or symptoms. When left untreated, this type of cancer can lead to a more aggressive form of leukemia known as blast crisis, which poses a life-threatening risk.

CML is usually diagnosed through blood tests and bone marrow biopsy. Treatment options for CML include medications called tyrosine kinase inhibitors, which target genetic mutations that cause this blood cancer. Some cases may also require bone marrow transplants.

There is no cure for CML, and it is a cancer that requires ongoing management and support. It is important for patients with CML to work closely with their healthcare providers in order to develop a treatment plan that is tailored to their individual needs. Many people with CML are able to live long and healthy lives with the right treatment and management.

We have compiled a comprehensive data pool of information covering CML on our website so you can learn more about this blood cancer.